ViaCyte's Unattributed VC - II Round

ViaCyte raised a round of funding on May 15, 2006.

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a therapy for the treatment of diabetes. The Company's lead product is based o…

Articles about ViaCyte's Unattributed VC - II Round: